199 filings
8-K
URGN
UroGen Pharma Ltd
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
424B5
URGN
UroGen Pharma Ltd
18 Jun 24
Prospectus supplement for primary offering
5:05pm
424B5
URGN
UroGen Pharma Ltd
17 Jun 24
Prospectus supplement for primary offering
4:19pm
8-K
URGN
UroGen Pharma Ltd
13 Jun 24
Regulation FD Disclosure
10:51am
10-Q
2024 Q1
URGN
UroGen Pharma Ltd
Quarterly report
13 May 24
8:05am
8-K
ji6cyf 6z
13 May 24
ENVISION data expected to support completion of UGN-102 NDA in Q3 2024
8:01am
8-K
o8xzp4e9l
14 Mar 24
UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102
8:16am
8-K
xmp 3mjvr7gwpw
4 Mar 24
Regulation FD Disclosure
7:00am
8-K
roh9i
1 Mar 24
Regulation FD Disclosure
7:00am
8-K
cfwy mlqhizg0u5efrdq
7 Feb 24
Regulation FD Disclosure
4:15pm
8-K
zz6 yythu
17 Jan 24
Entry into a Material Definitive Agreement
4:16pm
8-K
t02i9jg
2 Jan 24
Entry into a Material Definitive Agreement
8:04am
UPLOAD
gl846n et
5 Dec 23
Letter from SEC
12:00am
CORRESP
hsov 59u4zd
27 Nov 23
Correspondence with SEC
12:00am
UPLOAD
3cw7 kkn2cz342
16 Nov 23
Letter from SEC
12:00am
S-8
8pznehb u01qoh9ki7f
14 Nov 23
Registration of securities for employees
4:20pm
8-K
z0a7wc6fg1ksop
14 Nov 23
UroGen Pharma Reports Third Quarter 2023 Financial Results
12:00am